Cargando…
Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets
Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784263/ https://www.ncbi.nlm.nih.gov/pubmed/36548458 http://dx.doi.org/10.3390/proteomes10040039 |
_version_ | 1784857768679702528 |
---|---|
author | Möller, Jens Bodenschatz, Mona Sangal, Vartul Hofmann, Jörg Burkovski, Andreas |
author_facet | Möller, Jens Bodenschatz, Mona Sangal, Vartul Hofmann, Jörg Burkovski, Andreas |
author_sort | Möller, Jens |
collection | PubMed |
description | Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics and bioinformatics approach to characterize C. pseudotuberculosis 12CS0282. The genome sequence of strain 12CS0282 was determined, analyzed in comparison with the available 130 C. pseudotuberculosis sequences and used as a basis for proteome analyses. In a reverse vaccinology approach, putative vaccine and drug targets for 12CS0208 were identified. Mass spectrometry analyses revealed the presence of multiple virulence factors even without host contact. In macrophage interaction studies, C. pseudotuberculosis 12CS0282 was highly resistant against human phagocytes and even multiplied within human THP-1 cells. Taken together, the data indicate a high pathogenic potential of the strain. |
format | Online Article Text |
id | pubmed-9784263 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97842632022-12-24 Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets Möller, Jens Bodenschatz, Mona Sangal, Vartul Hofmann, Jörg Burkovski, Andreas Proteomes Article Corynebacterium pseudotuberculosis is an important animal pathogen, which is also able to infect humans. An optimal treatment of infections with this pathogen is not available today and consequently, more research is necessary to understand the infection process. Here, we present a combined -omics and bioinformatics approach to characterize C. pseudotuberculosis 12CS0282. The genome sequence of strain 12CS0282 was determined, analyzed in comparison with the available 130 C. pseudotuberculosis sequences and used as a basis for proteome analyses. In a reverse vaccinology approach, putative vaccine and drug targets for 12CS0208 were identified. Mass spectrometry analyses revealed the presence of multiple virulence factors even without host contact. In macrophage interaction studies, C. pseudotuberculosis 12CS0282 was highly resistant against human phagocytes and even multiplied within human THP-1 cells. Taken together, the data indicate a high pathogenic potential of the strain. MDPI 2022-11-23 /pmc/articles/PMC9784263/ /pubmed/36548458 http://dx.doi.org/10.3390/proteomes10040039 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Möller, Jens Bodenschatz, Mona Sangal, Vartul Hofmann, Jörg Burkovski, Andreas Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title | Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title_full | Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title_fullStr | Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title_full_unstemmed | Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title_short | Multi-Omics of Corynebacterium Pseudotuberculosis 12CS0282 and an In Silico Reverse Vaccinology Approach Reveal Novel Vaccine and Drug Targets |
title_sort | multi-omics of corynebacterium pseudotuberculosis 12cs0282 and an in silico reverse vaccinology approach reveal novel vaccine and drug targets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784263/ https://www.ncbi.nlm.nih.gov/pubmed/36548458 http://dx.doi.org/10.3390/proteomes10040039 |
work_keys_str_mv | AT mollerjens multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets AT bodenschatzmona multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets AT sangalvartul multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets AT hofmannjorg multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets AT burkovskiandreas multiomicsofcorynebacteriumpseudotuberculosis12cs0282andaninsilicoreversevaccinologyapproachrevealnovelvaccineanddrugtargets |